Pharma's Prescription [electronic resource] : How the Right Technology Can Save the Pharmaceutical Business
Biswas, Kamal.
Burlington : Elsevier Science,
2013.
 The pharmaceutical industry needs a shot in the arm - and not a moment too soon. The executive suite is mired in a bygone era, a time when extensive, well-funded pharmaceutical R&D produced blockbuster drugs, kept everything in-house and reaped the financial rewards. But that way of working needs to change. Executives now need to know what the technologists in their companies are doing in order to survive the next decade. Written for those new to industry, as well as for experienced professionals or specialists looking to expand their knowledge, this book is a must-read for business executi
Description based upon print version of record.
Chapter 4 - Courageous New World: Strategies to Improve Business OutcomesSTAGGERING GENIUS IN THE CROWD: NEXTGEN R&D; FEED YOUR WORKHORSE: SMARTER MANUFACTURING; PRODUCT FAST-TRACK: REMODEL THE SUPPLY CHAIN; IN DIGITAL WE TRUST: INDUSTRIALIZE CUSTOMER CENTRICITY; SCREAM WITH MOUTH SHUT: GLOBAL COMPLIANCE STRATEGY; WHY PATIENTS CONTINUE WITH MEDICINE: PATIENT ADHERENCE; THE PERKS IN EMERGING MARKETS: GO GLOBAL; Chapter 5 - Measuring Business Values and Success; THE PHARMA VALUE CYCLE: HOW TO REDEFINE STAKEHOLDER VALUES; THE UNBEARABLE FINANCIALS: MODELS TO REALIZE FINANCIAL VALUE; Index
 The pharmaceutical industry needs a shot in the arm - and not a moment too soon. The executive suite is mired in a bygone era, a time when extensive, well-funded pharmaceutical R&D produced blockbuster drugs, kept everything in-house and reaped the financial rewards. But that way of working needs to change. Executives now need to know what the technologists in their companies are doing in order to survive the next decade. Written for those new to industry, as well as for experienced professionals or specialists looking to expand their knowledge, this book is a must-read for business executi
Drug industry -- Economics --United States.
Drug utilization -- United States.
Drugs -- Social aspects -- United States.
Pharmaceutical industry -- United States.